Hemophilia interviews evaluation form

The evolution of hemostasis regulation

We value your opinion: please complete our evaluation form and provide your information to receive your CME credits.

Question Title

* 1. How would you rate the overall quality of this activity?

1=Poor, 10 = Excellent

Clear

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 2. To what extent did the interviews fulfil your educational goals and expected learning outcomes?

	Very much	Somewhat	Not much	Not at all	Undecided
Understand the physiological basis of the hemostatic system, and discuss both cell-based and cascade models of coagulation	Understand the physiological basis of the hemostatic system, and discuss both cell-based and cascade models of coagulation Very much	Understand the physiological basis of the hemostatic system, and discuss both cell-based and cascade models of coagulation Somewhat	Understand the physiological basis of the hemostatic system, and discuss both cell-based and cascade models of coagulation Not much	Understand the physiological basis of the hemostatic system, and discuss both cell-based and cascade models of coagulation Not at all	Understand the physiological basis of the hemostatic system, and discuss both cell-based and cascade models of coagulation Undecided
Identify new and emerging therapeutic options in phase 3 for hemophilia and describe their mode of action and physiological role in hemostasis	Identify new and emerging therapeutic options in phase 3 for hemophilia and describe their mode of action and physiological role in hemostasis Very much	Identify new and emerging therapeutic options in phase 3 for hemophilia and describe their mode of action and physiological role in hemostasis Somewhat	Identify new and emerging therapeutic options in phase 3 for hemophilia and describe their mode of action and physiological role in hemostasis Not much	Identify new and emerging therapeutic options in phase 3 for hemophilia and describe their mode of action and physiological role in hemostasis Not at all	Identify new and emerging therapeutic options in phase 3 for hemophilia and describe their mode of action and physiological role in hemostasis Undecided
Comprehend the complexity of balancing the hemostatic system, how clinicians understand and mitigate risk, and what happens with hemostasis if we disturb/re-balance the system with new therapeutic options	Comprehend the complexity of balancing the hemostatic system, how clinicians understand and mitigate risk, and what happens with hemostasis if we disturb/re-balance the system with new therapeutic options Very much	Comprehend the complexity of balancing the hemostatic system, how clinicians understand and mitigate risk, and what happens with hemostasis if we disturb/re-balance the system with new therapeutic options Somewhat	Comprehend the complexity of balancing the hemostatic system, how clinicians understand and mitigate risk, and what happens with hemostasis if we disturb/re-balance the system with new therapeutic options Not much	Comprehend the complexity of balancing the hemostatic system, how clinicians understand and mitigate risk, and what happens with hemostasis if we disturb/re-balance the system with new therapeutic options Not at all	Comprehend the complexity of balancing the hemostatic system, how clinicians understand and mitigate risk, and what happens with hemostasis if we disturb/re-balance the system with new therapeutic options Undecided
Discuss if and how treatment with non-factor therapies can be used, based on patient characteristics	Discuss if and how treatment with non-factor therapies can be used, based on patient characteristics Very much	Discuss if and how treatment with non-factor therapies can be used, based on patient characteristics Somewhat	Discuss if and how treatment with non-factor therapies can be used, based on patient characteristics Not much	Discuss if and how treatment with non-factor therapies can be used, based on patient characteristics Not at all	Discuss if and how treatment with non-factor therapies can be used, based on patient characteristics Undecided
Interpret how the mechanism of action of new therapeutic options impacts the efficacy and safety results in clinical practice, and compare the safety outcomes of new therapies with those generally used in hemophilia patients	Interpret how the mechanism of action of new therapeutic options impacts the efficacy and safety results in clinical practice, and compare the safety outcomes of new therapies with those generally used in hemophilia patients Very much	Interpret how the mechanism of action of new therapeutic options impacts the efficacy and safety results in clinical practice, and compare the safety outcomes of new therapies with those generally used in hemophilia patients Somewhat	Interpret how the mechanism of action of new therapeutic options impacts the efficacy and safety results in clinical practice, and compare the safety outcomes of new therapies with those generally used in hemophilia patients Not much	Interpret how the mechanism of action of new therapeutic options impacts the efficacy and safety results in clinical practice, and compare the safety outcomes of new therapies with those generally used in hemophilia patients Not at all	Interpret how the mechanism of action of new therapeutic options impacts the efficacy and safety results in clinical practice, and compare the safety outcomes of new therapies with those generally used in hemophilia patients Undecided

Question Title

* 3. Please rate the interviews based on the following criteria:
This activity…

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
was based on relevant and current evidence	was based on relevant and current evidence Strongly agree	was based on relevant and current evidence Agree	was based on relevant and current evidence Neutral	was based on relevant and current evidence Disagree	was based on relevant and current evidence Strongly disagree
increased my knowledge of the topic	increased my knowledge of the topic Strongly agree	increased my knowledge of the topic Agree	increased my knowledge of the topic Neutral	increased my knowledge of the topic Disagree	increased my knowledge of the topic Strongly disagree
focused on competencies relevant to my practice	focused on competencies relevant to my practice Strongly agree	focused on competencies relevant to my practice Agree	focused on competencies relevant to my practice Neutral	focused on competencies relevant to my practice Disagree	focused on competencies relevant to my practice Strongly disagree
will help me improve patient care within my clinical practice	will help me improve patient care within my clinical practice Strongly agree	will help me improve patient care within my clinical practice Agree	will help me improve patient care within my clinical practice Neutral	will help me improve patient care within my clinical practice Disagree	will help me improve patient care within my clinical practice Strongly disagree

Question Title

* 4. How useful to you personally was each session?

	Extremely useful	Useful	Fairly useful	Not useful	Undecided/DNA
How does the hemostatic system work?	How does the hemostatic system work? Extremely useful	How does the hemostatic system work? Useful	How does the hemostatic system work? Fairly useful	How does the hemostatic system work? Not useful	How does the hemostatic system work? Undecided/DNA
What are the new and emerging therapeutic options involved in hemostatic regulation?	What are the new and emerging therapeutic options involved in hemostatic regulation? Extremely useful	What are the new and emerging therapeutic options involved in hemostatic regulation? Useful	What are the new and emerging therapeutic options involved in hemostatic regulation? Fairly useful	What are the new and emerging therapeutic options involved in hemostatic regulation? Not useful	What are the new and emerging therapeutic options involved in hemostatic regulation? Undecided/DNA
How can we translate the research data in clinical practice outcomes?	How can we translate the research data in clinical practice outcomes? Extremely useful	How can we translate the research data in clinical practice outcomes? Useful	How can we translate the research data in clinical practice outcomes? Fairly useful	How can we translate the research data in clinical practice outcomes? Not useful	How can we translate the research data in clinical practice outcomes? Undecided/DNA

Question Title

* 5. As a result of participating in this activity, will you make any measurable changes in your role?

Yes

Possibly, after additional training/information

No, but the content affirms my current daily practice

No, I am unable to implement the information

Question Title

* 6. Do you agree that the information was overall free of commercial and other bias?

Strongly agree

Agree

Rather disagree

Strongly disagree

Undecided/Don't know

Question Title

* 7. CME credits

If you would like to receive a CME certificate for this activity please provide the information below:”

Email address:

First and last names:

Profession

Question Title

* 8. Use this form below to record your participation in the video interviews accredited by North American Center for Continuing Medical Education (NACCME).

Please note: Each video viewed is equivalent to 0.25 CME credit

	Watched? (Select the completed sessions)
How does the hemostatic system work? Chowdary & Mast (0.25 credit)	How does the hemostatic system work? Chowdary & Mast (0.25 credit) Watched? (Select the completed sessions)
What are the new and emerging therapeutic options involved in hemostatic regulation? Chowdary & Young (0.25 credit)	What are the new and emerging therapeutic options involved in hemostatic regulation? Chowdary & Young (0.25 credit) Watched? (Select the completed sessions)
How can we translate the research data in clinical practice outcomes? Chowdary & Mancuso (0.25 credit)	How can we translate the research data in clinical practice outcomes? Chowdary & Mancuso (0.25 credit) Watched? (Select the completed sessions)

Question Title

* 1. How would you rate the overall quality of this activity?1=Poor, 10 = Excellent

Question Title

* 2. To what extent did the interviews fulfil your educational goals and expected learning outcomes?

Question Title

* 3. Please rate the interviews based on the following criteria:This activity…

Question Title

* 4. How useful to you personally was each session?

Question Title

* 5. As a result of participating in this activity, will you make any measurable changes in your role?

Question Title

* 6. Do you agree that the information was overall free of commercial and other bias?

Question Title

* 7. CME creditsIf you would like to receive a CME certificate for this activity please provide the information below:”

Question Title

* 8. Use this form below to record your participation in the video interviews accredited by North American Center for Continuing Medical Education (NACCME). Please note: Each video viewed is equivalent to 0.25 CME credit

Question Title

* 9. Do you have any final questions or comments?

* 1. How would you rate the overall quality of this activity?

1=Poor, 10 = Excellent

* 3. Please rate the interviews based on the following criteria:
This activity…

* 7. CME credits

If you would like to receive a CME certificate for this activity please provide the information below:”

* 8. Use this form below to record your participation in the video interviews accredited by North American Center for Continuing Medical Education (NACCME).

Please note: Each video viewed is equivalent to 0.25 CME credit